Global Hepatic Encephalopathy Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hepatic Encephalopathy Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Hepatic encephalopathy (HE) is a severe complication of TIPS treatment in patients with cirrhosis and variceal bleeding. Lactulose, is considered the first-line therapeutic agent for treating hepatic encephalopathy. Based on route of administration, Hepatic Encephalopathy Drugs include oral (tablets & solutions) and injections.
Hepatic Encephalopathy Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hepatic Encephalopathy Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Hepatic Encephalopathy Drugs industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Hepatic Encephalopathy Drugs key manufacturers include ASKA Pharmaceutical, Cosmo Pharmaceuticals, Bausch Health, Ferring Pharmaceuticals, Mallinckrodt, Umecrine Cognition, Norgine, Lupin and Kaleido Biosciences, etc. ASKA Pharmaceutical, Cosmo Pharmaceuticals, Bausch Health are top 3 players and held % sales share in total in 2022.
Hepatic Encephalopathy Drugs can be divided into Injection and Oral, etc. Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Hepatic Encephalopathy Drugs is widely used in various fields, such as Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Hepatic Encephalopathy Drugs industry development. In 2022, global % sales of Hepatic Encephalopathy Drugs went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hepatic Encephalopathy Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company

ASKA Pharmaceutical
Cosmo Pharmaceuticals
Bausch Health
Ferring Pharmaceuticals
Mallinckrodt
Umecrine Cognition
Norgine
Lupin
Kaleido Biosciences
Kannalife Sciences
Segment by Type
Injection
Oral

Segment by Application

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Hepatic Encephalopathy Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hepatic Encephalopathy Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hepatic Encephalopathy Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Hepatic Encephalopathy Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hepatic Encephalopathy Drugs introduction, etc. Hepatic Encephalopathy Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hepatic Encephalopathy Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Hepatic Encephalopathy Drugs Market Overview
1.1 Hepatic Encephalopathy Drugs Product Overview
1.2 Hepatic Encephalopathy Drugs Market Segment by Type
1.2.1 Injection
1.2.2 Oral
1.3 Global Hepatic Encephalopathy Drugs Market Size by Type
1.3.1 Global Hepatic Encephalopathy Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global Hepatic Encephalopathy Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global Hepatic Encephalopathy Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hepatic Encephalopathy Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe Hepatic Encephalopathy Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Hepatic Encephalopathy Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Hepatic Encephalopathy Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Hepatic Encephalopathy Drugs Sales Breakdown by Type (2024-2024)
2 Global Hepatic Encephalopathy Drugs Market Competition by Company
2.1 Global Top Players by Hepatic Encephalopathy Drugs Sales (2024-2024)
2.2 Global Top Players by Hepatic Encephalopathy Drugs Revenue (2024-2024)
2.3 Global Top Players by Hepatic Encephalopathy Drugs Price (2024-2024)
2.4 Global Top Manufacturers Hepatic Encephalopathy Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hepatic Encephalopathy Drugs Market Competitive Situation and Trends
2.5.1 Hepatic Encephalopathy Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hepatic Encephalopathy Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatic Encephalopathy Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Hepatic Encephalopathy Drugs Market
2.8 Key Manufacturers Hepatic Encephalopathy Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hepatic Encephalopathy Drugs Status and Outlook by Region
3.1 Global Hepatic Encephalopathy Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Hepatic Encephalopathy Drugs Historic Market Size by Region
3.2.1 Global Hepatic Encephalopathy Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global Hepatic Encephalopathy Drugs Sales in Value by Region (2024-2024)
3.2.3 Global Hepatic Encephalopathy Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Hepatic Encephalopathy Drugs Forecasted Market Size by Region
3.3.1 Global Hepatic Encephalopathy Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Hepatic Encephalopathy Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Hepatic Encephalopathy Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Hepatic Encephalopathy Drugs by Application
4.1 Hepatic Encephalopathy Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Hepatic Encephalopathy Drugs Market Size by Application
4.2.1 Global Hepatic Encephalopathy Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global Hepatic Encephalopathy Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global Hepatic Encephalopathy Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hepatic Encephalopathy Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe Hepatic Encephalopathy Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Hepatic Encephalopathy Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Hepatic Encephalopathy Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Hepatic Encephalopathy Drugs Sales Breakdown by Application (2024-2024)
5 North America Hepatic Encephalopathy Drugs by Country
5.1 North America Hepatic Encephalopathy Drugs Historic Market Size by Country
5.1.1 North America Hepatic Encephalopathy Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Hepatic Encephalopathy Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America Hepatic Encephalopathy Drugs Sales in Value by Country (2024-2024)
5.2 North America Hepatic Encephalopathy Drugs Forecasted Market Size by Country
5.2.1 North America Hepatic Encephalopathy Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Hepatic Encephalopathy Drugs Sales in Value by Country (2024-2034)
6 Europe Hepatic Encephalopathy Drugs by Country
6.1 Europe Hepatic Encephalopathy Drugs Historic Market Size by Country
6.1.1 Europe Hepatic Encephalopathy Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Hepatic Encephalopathy Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe Hepatic Encephalopathy Drugs Sales in Value by Country (2024-2024)
6.2 Europe Hepatic Encephalopathy Drugs Forecasted Market Size by Country
6.2.1 Europe Hepatic Encephalopathy Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Hepatic Encephalopathy Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Hepatic Encephalopathy Drugs by Region
7.1 Asia-Pacific Hepatic Encephalopathy Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Hepatic Encephalopathy Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Hepatic Encephalopathy Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Hepatic Encephalopathy Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Hepatic Encephalopathy Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Hepatic Encephalopathy Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Hepatic Encephalopathy Drugs Sales in Value by Region (2024-2034)
8 Latin America Hepatic Encephalopathy Drugs by Country
8.1 Latin America Hepatic Encephalopathy Drugs Historic Market Size by Country
8.1.1 Latin America Hepatic Encephalopathy Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Hepatic Encephalopathy Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America Hepatic Encephalopathy Drugs Sales in Value by Country (2024-2024)
8.2 Latin America Hepatic Encephalopathy Drugs Forecasted Market Size by Country
8.2.1 Latin America Hepatic Encephalopathy Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Hepatic Encephalopathy Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Hepatic Encephalopathy Drugs by Country
9.1 Middle East and Africa Hepatic Encephalopathy Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Hepatic Encephalopathy Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Hepatic Encephalopathy Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Hepatic Encephalopathy Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Hepatic Encephalopathy Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Hepatic Encephalopathy Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Hepatic Encephalopathy Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 ASKA Pharmaceutical
10.1.1 ASKA Pharmaceutical Company Information
10.1.2 ASKA Pharmaceutical Introduction and Business Overview
10.1.3 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 ASKA Pharmaceutical Hepatic Encephalopathy Drugs Products Offered
10.1.5 ASKA Pharmaceutical Recent Development
10.2 Cosmo Pharmaceuticals
10.2.1 Cosmo Pharmaceuticals Company Information
10.2.2 Cosmo Pharmaceuticals Introduction and Business Overview
10.2.3 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Products Offered
10.2.5 Cosmo Pharmaceuticals Recent Development
10.3 Bausch Health
10.3.1 Bausch Health Company Information
10.3.2 Bausch Health Introduction and Business Overview
10.3.3 Bausch Health Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Bausch Health Hepatic Encephalopathy Drugs Products Offered
10.3.5 Bausch Health Recent Development
10.4 Ferring Pharmaceuticals
10.4.1 Ferring Pharmaceuticals Company Information
10.4.2 Ferring Pharmaceuticals Introduction and Business Overview
10.4.3 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Products Offered
10.4.5 Ferring Pharmaceuticals Recent Development
10.5 Mallinckrodt
10.5.1 Mallinckrodt Company Information
10.5.2 Mallinckrodt Introduction and Business Overview
10.5.3 Mallinckrodt Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Mallinckrodt Hepatic Encephalopathy Drugs Products Offered
10.5.5 Mallinckrodt Recent Development
10.6 Umecrine Cognition
10.6.1 Umecrine Cognition Company Information
10.6.2 Umecrine Cognition Introduction and Business Overview
10.6.3 Umecrine Cognition Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Umecrine Cognition Hepatic Encephalopathy Drugs Products Offered
10.6.5 Umecrine Cognition Recent Development
10.7 Norgine
10.7.1 Norgine Company Information
10.7.2 Norgine Introduction and Business Overview
10.7.3 Norgine Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Norgine Hepatic Encephalopathy Drugs Products Offered
10.7.5 Norgine Recent Development
10.8 Lupin
10.8.1 Lupin Company Information
10.8.2 Lupin Introduction and Business Overview
10.8.3 Lupin Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Lupin Hepatic Encephalopathy Drugs Products Offered
10.8.5 Lupin Recent Development
10.9 Kaleido Biosciences
10.9.1 Kaleido Biosciences Company Information
10.9.2 Kaleido Biosciences Introduction and Business Overview
10.9.3 Kaleido Biosciences Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Kaleido Biosciences Hepatic Encephalopathy Drugs Products Offered
10.9.5 Kaleido Biosciences Recent Development
10.10 Kannalife Sciences
10.10.1 Kannalife Sciences Company Information
10.10.2 Kannalife Sciences Introduction and Business Overview
10.10.3 Kannalife Sciences Hepatic Encephalopathy Drugs Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Kannalife Sciences Hepatic Encephalopathy Drugs Products Offered
10.10.5 Kannalife Sciences Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hepatic Encephalopathy Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hepatic Encephalopathy Drugs Industrial Chain Analysis
11.4 Hepatic Encephalopathy Drugs Market Dynamics
11.4.1 Hepatic Encephalopathy Drugs Industry Trends
11.4.2 Hepatic Encephalopathy Drugs Market Drivers
11.4.3 Hepatic Encephalopathy Drugs Market Challenges
11.4.4 Hepatic Encephalopathy Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hepatic Encephalopathy Drugs Distributors
12.3 Hepatic Encephalopathy Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Injection
Table 2. Major Company of Oral
Table 3. Global Hepatic Encephalopathy Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Hepatic Encephalopathy Drugs Sales by Type (2024-2024) & (MT)
Table 5. Global Hepatic Encephalopathy Drugs Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Hepatic Encephalopathy Drugs Sales by Type (2024-2024) & (US& Million)
Table 7. Global Hepatic Encephalopathy Drugs Market Share in Value by Type (2024-2024)
Table 8. Global Hepatic Encephalopathy Drugs Price by Type (2024-2024) & (USD/Kg)
Table 9. Global Hepatic Encephalopathy Drugs Sales by Type (2024-2034) & (MT)
Table 10. Global Hepatic Encephalopathy Drugs Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Hepatic Encephalopathy Drugs Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Hepatic Encephalopathy Drugs Sales Market Share in Value by Type (2024-2034)
Table 13. Global Hepatic Encephalopathy Drugs Price by Type (2024-2034) & (USD/Kg)
Table 14. North America Hepatic Encephalopathy Drugs Sales by Type (2024-2024) & (MT)
Table 15. North America Hepatic Encephalopathy Drugs Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Hepatic Encephalopathy Drugs Sales (MT) by Type (2024-2024)
Table 17. Europe Hepatic Encephalopathy Drugs Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Hepatic Encephalopathy Drugs Sales (MT) by Type (2024-2024)
Table 19. Asia-Pacific Hepatic Encephalopathy Drugs Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Hepatic Encephalopathy Drugs Sales (MT) by Type (2024-2024)
Table 21. Latin America Hepatic Encephalopathy Drugs Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Hepatic Encephalopathy Drugs Sales (MT) by Type (2024-2024)
Table 23. Middle East and Africa Hepatic Encephalopathy Drugs Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Hepatic Encephalopathy Drugs Sales by Company (2024-2024) & (MT)
Table 25. Global Hepatic Encephalopathy Drugs Sales Share by Company (2024-2024)
Table 26. Global Hepatic Encephalopathy Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Hepatic Encephalopathy Drugs Revenue Share by Company (2024-2024)
Table 28. Global Market Hepatic Encephalopathy Drugs Price by Company (2024-2024) & (USD/Kg)
Table 29. Global Hepatic Encephalopathy Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Hepatic Encephalopathy Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hepatic Encephalopathy Drugs as of 2022)
Table 32. Date of Key Manufacturers Enter into Hepatic Encephalopathy Drugs Market
Table 33. Key Manufacturers Hepatic Encephalopathy Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Hepatic Encephalopathy Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Hepatic Encephalopathy Drugs Sales by Region (2024-2024) & (MT)
Table 37. Global Hepatic Encephalopathy Drugs Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Hepatic Encephalopathy Drugs Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Hepatic Encephalopathy Drugs Sales Market Share in Value by Region (2024-2024)
Table 40. Global Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2024)
Table 41. Global Hepatic Encephalopathy Drugs Sales by Region (2024-2034) & (MT)
Table 42. Global Hepatic Encephalopathy Drugs Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Hepatic Encephalopathy Drugs Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Hepatic Encephalopathy Drugs Sales Market Share in Value by Region (2024-2034)
Table 45. Global Hepatic Encephalopathy Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2034)
Table 46. Global Hepatic Encephalopathy Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Hepatic Encephalopathy Drugs Sales by Application (2024-2024) & (MT)
Table 48. Global Hepatic Encephalopathy Drugs Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Hepatic Encephalopathy Drugs Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Hepatic Encephalopathy Drugs Sales Market Share in Value by Application (2024-2024)
Table 51. Global Hepatic Encephalopathy Drugs Price by Application (2024-2024) & (USD/Kg)
Table 52. Global Hepatic Encephalopathy Drugs Sales by Application (2024-2034) & (MT)
Table 53. Global Hepatic Encephalopathy Drugs Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Hepatic Encephalopathy Drugs Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Hepatic Encephalopathy Drugs Sales Market Share in Value by Application (2024-2034)
Table 56. Global Hepatic Encephalopathy Drugs Price by Application (2024-2034) & (USD/Kg)
Table 57. North America Hepatic Encephalopathy Drugs Sales by Application (2024-2024) (MT)
Table 58. North America Hepatic Encephalopathy Drugs Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Hepatic Encephalopathy Drugs Sales by Application (2024-2024) (MT)
Table 60. Europe Hepatic Encephalopathy Drugs Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Hepatic Encephalopathy Drugs Sales by Application (2024-2024) (MT)
Table 62. Asia-Pacific Hepatic Encephalopathy Drugs Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Hepatic Encephalopathy Drugs Sales by Application (2024-2024) (MT)
Table 64. Latin America Hepatic Encephalopathy Drugs Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Hepatic Encephalopathy Drugs Sales by Application (2024-2024) (MT)
Table 66. Middle East and Africa Hepatic Encephalopathy Drugs Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Hepatic Encephalopathy Drugs Sales by Country (2024-2024) & (MT)
Table 68. North America Hepatic Encephalopathy Drugs Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Hepatic Encephalopathy Drugs Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Hepatic Encephalopathy Drugs Sales Market Share in Value by Country (2024-2024)
Table 71. North America Hepatic Encephalopathy Drugs Sales by Country (2024-2034) & (MT)
Table 72. North America Hepatic Encephalopathy Drugs Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Hepatic Encephalopathy Drugs Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Hepatic Encephalopathy Drugs Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Hepatic Encephalopathy Drugs Sales by Country (2024-2024) & (MT)
Table 76. Europe Hepatic Encephalopathy Drugs Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Hepatic Encephalopathy Drugs Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Hepatic Encephalopathy Drugs Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Hepatic Encephalopathy Drugs Sales by Country (2024-2034) & (MT)
Table 80. Europe Hepatic Encephalopathy Drugs Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Hepatic Encephalopathy Drugs Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Hepatic Encephalopathy Drugs Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Hepatic Encephalopathy Drugs Sales by Region (2024-2024) & (MT)
Table 84. Asia-Pacific Hepatic Encephalopathy Drugs Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Hepatic Encephalopathy Drugs Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Hepatic Encephalopathy Drugs Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Hepatic Encephalopathy Drugs Sales by Region (2024-2034) & (MT)
Table 88. Asia-Pacific Hepatic Encephalopathy Drugs Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Hepatic Encephalopathy Drugs Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Hepatic Encephalopathy Drugs Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Hepatic Encephalopathy Drugs Sales by Country (2024-2024) & (MT)
Table 92. Latin America Hepatic Encephalopathy Drugs Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Hepatic Encephalopathy Drugs Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Hepatic Encephalopathy Drugs Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Hepatic Encephalopathy Drugs Sales by Country (2024-2034) & (MT)
Table 96. Latin America Hepatic Encephalopathy Drugs Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Hepatic Encephalopathy Drugs Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Hepatic Encephalopathy Drugs Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Hepatic Encephalopathy Drugs Sales by Country (2024-2024) & (MT)
Table 100. Middle East and Africa Hepatic Encephalopathy Drugs Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Hepatic Encephalopathy Drugs Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Hepatic Encephalopathy Drugs Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Hepatic Encephalopathy Drugs Sales by Country (2024-2034) & (MT)
Table 104. Middle East and Africa Hepatic Encephalopathy Drugs Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Hepatic Encephalopathy Drugs Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Hepatic Encephalopathy Drugs Sales Market Share in Value by Country (2024-2034)
Table 107. ASKA Pharmaceutical Company Information
Table 108. ASKA Pharmaceutical Introduction and Business Overview
Table 109. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 110. ASKA Pharmaceutical Hepatic Encephalopathy Drugs Product
Table 111. ASKA Pharmaceutical Recent Development
Table 112. Cosmo Pharmaceuticals Company Information
Table 113. Cosmo Pharmaceuticals Introduction and Business Overview
Table 114. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 115. Cosmo Pharmaceuticals Hepatic Encephalopathy Drugs Product
Table 116. Cosmo Pharmaceuticals Recent Development
Table 117. Bausch Health Company Information
Table 118. Bausch Health Introduction and Business Overview
Table 119. Bausch Health Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 120. Bausch Health Hepatic Encephalopathy Drugs Product
Table 121. Bausch Health Recent Development
Table 122. Ferring Pharmaceuticals Company Information
Table 123. Ferring Pharmaceuticals Introduction and Business Overview
Table 124. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 125. Ferring Pharmaceuticals Hepatic Encephalopathy Drugs Product
Table 126. Ferring Pharmaceuticals Recent Development
Table 127. Mallinckrodt Company Information
Table 128. Mallinckrodt Introduction and Business Overview
Table 129. Mallinckrodt Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 130. Mallinckrodt Hepatic Encephalopathy Drugs Product
Table 131. Mallinckrodt Recent Development
Table 132. Umecrine Cognition Company Information
Table 133. Umecrine Cognition Introduction and Business Overview
Table 134. Umecrine Cognition Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 135. Umecrine Cognition Hepatic Encephalopathy Drugs Product
Table 136. Umecrine Cognition Recent Development
Table 137. Norgine Company Information
Table 138. Norgine Introduction and Business Overview
Table 139. Norgine Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 140. Norgine Hepatic Encephalopathy Drugs Product
Table 141. Norgine Recent Development
Table 142. Lupin Company Information
Table 143. Lupin Introduction and Business Overview
Table 144. Lupin Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 145. Lupin Hepatic Encephalopathy Drugs Product
Table 146. Lupin Recent Development
Table 147. Kaleido Biosciences Company Information
Table 148. Kaleido Biosciences Introduction and Business Overview
Table 149. Kaleido Biosciences Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 150. Kaleido Biosciences Hepatic Encephalopathy Drugs Product
Table 151. Kaleido Biosciences Recent Development
Table 152. Kannalife Sciences Company Information
Table 153. Kannalife Sciences Introduction and Business Overview
Table 154. Kannalife Sciences Hepatic Encephalopathy Drugs Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 155. Kannalife Sciences Hepatic Encephalopathy Drugs Product
Table 156. Kannalife Sciences Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Hepatic Encephalopathy Drugs Market Trends
Table 160. Hepatic Encephalopathy Drugs Market Drivers
Table 161. Hepatic Encephalopathy Drugs Market Challenges
Table 162. Hepatic Encephalopathy Drugs Market Restraints
Table 163. Hepatic Encephalopathy Drugs Distributors List
Table 164. Hepatic Encephalopathy Drugs Downstream Customers
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepatic Encephalopathy Drugs Product Picture
Figure 2. Global Hepatic Encephalopathy Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Hepatic Encephalopathy Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Hepatic Encephalopathy Drugs Sales Status and Outlook (2024-2034) & (MT)
Figure 5. Product Picture of Injection
Figure 6. Global Injection Sales YoY Growth (2024-2034) & (MT)
Figure 7. Product Picture of Oral
Figure 8. Global Oral Sales YoY Growth (2024-2034) & (MT)
Figure 9. Global Hepatic Encephalopathy Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Hepatic Encephalopathy Drugs Sales Market Share by Type in 2022 & 2034
Figure 11. North America Hepatic Encephalopathy Drugs Sales Market Share in Volume by Type in 2022
Figure 12. North America Hepatic Encephalopathy Drugs Sales Market Share in Value by Type in 2022
Figure 13. Europe Hepatic Encephalopathy Drugs Sales Market Share in Volume by Type in 2022
Figure 14. Europe Hepatic Encephalopathy Drugs Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Hepatic Encephalopathy Drugs Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Hepatic Encephalopathy Drugs Sales Market Share in Value by Type in 2022
Figure 17. Latin America Hepatic Encephalopathy Drugs Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Hepatic Encephalopathy Drugs Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Hepatic Encephalopathy Drugs Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Hepatic Encephalopathy Drugs Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Hepatic Encephalopathy Drugs Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Hepatic Encephalopathy Drugs Revenue in 2022
Figure 23. Hepatic Encephalopathy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital Pharmacies
Figure 25. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (MT)
Figure 26. Product Picture of Retail Pharmacies
Figure 27. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (MT)
Figure 28. Product Picture of Online Pharmacies
Figure 29. Global Online Pharmacies Sales YoY Growth (2024-2034) & (MT)
Figure 30. Global Hepatic Encephalopathy Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Hepatic Encephalopathy Drugs Sales Market Share by Application in 2022 & 2034
Figure 32. North America Hepatic Encephalopathy Drugs Sales Market Share in Volume by Application in 2022
Figure 33. North America Hepatic Encephalopathy Drugs Sales Market Share in Value by Application in 2022
Figure 34. Europe Hepatic Encephalopathy Drugs Sales Market Share in Volume by Application in 2022
Figure 35. Europe Hepatic Encephalopathy Drugs Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Hepatic Encephalopathy Drugs Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Hepatic Encephalopathy Drugs Sales Market Share in Value by Application in 2022
Figure 38. Latin America Hepatic Encephalopathy Drugs Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Hepatic Encephalopathy Drugs Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Hepatic Encephalopathy Drugs Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Hepatic Encephalopathy Drugs Manufacturing Cost Structure
Figure 43. Hepatic Encephalopathy Drugs Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Global Hepatic Encephalopathy Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Global Hepatic Encephalopathy Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

By Company

Segment by Application

Segment by Region

Table of Content

List of Figure

Select User License

$4200 Single Licence

$6000 Enterprise Licence

$9100 Corporate Licence

Note : All prices in USD

FAQ'S

User License?

Delivery Time?

How do I place an order?

What is the Payment Options?

Is there a discount for multiple purchases?

Mode of Report Delivery?

Top Industries